Drugs / mPnC candidate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06116591 | Nov 2023 → May 2024 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mPnC candidate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06116591 ↗ |
| Modality | Vaccine | “monovalent pneumococcal conjugate candidate” NCT06116591 ↗ |